Canadian Microarray Firm Gets VC Nod, Again
Epocal of Ottawa received CA $3.1 ($2.0) million in early-stage venture capital funding from Genesys Capital Partners. Genesys was the sole investor in the latest round, drawing funds from the New Generation Biotech Equity Fund, a labor-sponsored fund administered by Toronto-based Triax-Covington. The firm now has some $6.5 million invested in Epocal.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
